September 11, 2025 Financial Notice Concerning Partial Amendment to the Shareholder Benefit Program (PDF 149.46 KB)
August 25, 2025 Financial Terumo to acquire OrganOx Limited, a leading innovator in organ preservation devices, marking strategic entry into the organ transplantation-related sector (PDF 186.45 KB) - Expanding opportunities for organ transplantation worldwide and contributing to the advancement of transplant medicine -
August 04, 2025 Financial Notice Concerning Completion of Disposal of Treasury Shares as Restricted Stock Remuneration (PDF 111.15 KB)
Top Management Message Message from top management to shareholders and investors. /investors/management/message Corporate Governance /about/governance Compliance /about/compliance Leadership Team /about/leadership Business Risks Major risks that may affect the business performance and financial position of the Terumo Group are described. /investors/management/risk IR Policy /investors/management/ir_policy Disclaimer /investors/disclaimer
